The c-ros oncogene 1 (ROS1) rearrangements, detected in 1%~2% of NSCLC [5–9] and up to 3% in lung adenocarcinoma [10, 11], represent a novel molecular subgroup of NSCLC. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.